Linde India (523457) Q4 2020 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2020 earnings summary
14 Oct, 2026Executive summary
FY2020 revenue fell 16.5% YoY, reflecting the prior-year South Region divestment and COVID-19 disruption; underlying gases revenue grew ~3%.
Profit before tax before exceptional items rose to Rs 2,252.42 million, while net profit fell sharply against FY2019’s one-off divestment gain.
Healthcare oxygen demand, operational resilience and a Project Engineering order book above Rs 11,000 million supported the business outlook.
Financial highlights
Revenue from operations was Rs 14,711.24 million, down 16.5% YoY; EBITDA was Rs 4,074.85 million versus Rs 4,356.54 million.
EBIT was Rs 2,314.85 million versus Rs 2,584.00 million; PBT before exceptional items increased to Rs 2,252.42 million from Rs 1,721.50 million.
Net profit was Rs 1,555.35 million versus Rs 7,271.79 million; FY2019 included an Rs 8,407.55 million exceptional gain from the South Region business sale.
Excluding the prior-year divestment gain, FY2020 exceptional profit was Rs 111.48 million, from additional consideration and reversal of provisions.
Outlook and guidance
Management expected the recovery across steel, automotive, pharma, chemicals, cement, food and infrastructure to support gases demand; COVID-19 remained an ongoing uncertainty.
Project Engineering order book exceeded Rs 11,000 million at 31 Dec 2020; refinery and steel expansion plans were identified as growth opportunities.
The Board proposed a 30% dividend, or Rs 3 per share, subject to shareholder approval; expected cash outflow was Rs 255.85 million.
Latest events from Linde India
- Record EBITDA and debt reduction, but divestment drove reported profit amid COVID-19 uncertainty.523457
Q4 2019 - FY21 rebounded strongly, though reported profit included a major land-sale gain.523457
Q4 2021 - Strong growth, a debt-free balance sheet and a Rs 14,200 million PED order book.523457
Q4 22/23 - Revenue and EBITDA grew, led by Gases, amid unresolved related-party proceedings.523457
Q4 23/24 - Strong revenue growth and segment results, but regulatory proceedings create uncertainty.523457
Q1 26/27 - Strong financial results and dividend, but regulatory/legal uncertainties led to a qualified audit opinion.523457
Q4 25/26 - Q3 FY26 profit after tax rose to ₹1,933.25 million amid ongoing regulatory uncertainties.523457
Q3 25/26 - Q2 FY26 saw strong revenue and profit growth, but regulatory risks remain elevated.523457
Q2 25/26 - Quarterly profit and revenue declined year-over-year amid ongoing SEBI regulatory scrutiny.523457
Q3 24/25